Protein aggregation and neurodegenerative disease
- PMID: 15272267
- DOI: 10.1038/nm1066
Protein aggregation and neurodegenerative disease
Abstract
Neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD), amyotrophic lateral sclerosis (ALS) and prion diseases are increasingly being realized to have common cellular and molecular mechanisms including protein aggregation and inclusion body formation. The aggregates usually consist of fibers containing misfolded protein with a beta-sheet conformation, termed amyloid. There is partial but not perfect overlap among the cells in which abnormal proteins are deposited and the cells that degenerate. The most likely explanation is that inclusions and other visible protein aggregates represent an end stage of a molecular cascade of several steps, and that earlier steps in the cascade may be more directly tied to pathogenesis than the inclusions themselves. For several diseases, genetic variants assist in explaining the pathogenesis of the more common sporadic forms and developing mouse and other models. There is now increased understanding of the pathways involved in protein aggregation, and some recent clues have emerged as to the molecular mechanisms of cellular toxicity. These are leading to approaches toward rational therapeutics.
Similar articles
-
Targeting oligomers in neurodegenerative disorders: lessons from α-synuclein, tau, and amyloid-β peptide.J Alzheimers Dis. 2011;24 Suppl 2:223-32. doi: 10.3233/JAD-2011-110182. J Alzheimers Dis. 2011. PMID: 21460436 Review.
-
[Neurodegenerative conformational disease and its molecular bases].Sheng Li Ke Xue Jin Zhan. 2006 Apr;37(2):97-102. Sheng Li Ke Xue Jin Zhan. 2006. PMID: 16850610 Review. Chinese.
-
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategies.Exp Mol Med. 2015 Mar 13;47(3):e147. doi: 10.1038/emm.2014.117. Exp Mol Med. 2015. PMID: 25766616 Free PMC article. Review.
-
Unbiased screen reveals ubiquilin-1 and -2 highly associated with huntingtin inclusions.Brain Res. 2013 Aug 2;1524:62-73. doi: 10.1016/j.brainres.2013.06.006. Epub 2013 Jun 15. Brain Res. 2013. PMID: 23774650 Free PMC article.
-
Preventing misfolded neuronal protein aggregation by molecular diplomacy.Neurosci Lett. 2009 Jan 9;449(2):85-6. doi: 10.1016/j.neulet.2008.10.068. Epub 2008 Nov 1. Neurosci Lett. 2009. PMID: 18977276 No abstract available.
Cited by 814 articles
-
4-Phenylbutyrate ameliorates apoptotic neural cell death in Down syndrome by reducing protein aggregates.Sci Rep. 2020 Aug 20;10(1):14047. doi: 10.1038/s41598-020-70362-x. Sci Rep. 2020. PMID: 32820178 Free PMC article.
-
α-synuclein strains that cause distinct pathologies differentially inhibit proteasome.Elife. 2020 Jul 22;9:e56825. doi: 10.7554/eLife.56825. Elife. 2020. PMID: 32697196 Free PMC article.
-
Meta-Analysis of the Alzheimer's Disease Human Brain Transcriptome and Functional Dissection in Mouse Models.Cell Rep. 2020 Jul 14;32(2):107908. doi: 10.1016/j.celrep.2020.107908. Cell Rep. 2020. PMID: 32668255 Free PMC article.
-
Effects of Airborne Nanoparticles on the Nervous System: Amyloid Protein Aggregation, Neurodegeneration and Neurodegenerative Diseases.Nanomaterials (Basel). 2020 Jul 10;10(7):1349. doi: 10.3390/nano10071349. Nanomaterials (Basel). 2020. PMID: 32664217 Free PMC article. Review.
-
Heptameric Peptide Interferes with Amyloid-β Aggregation by Structural Reorganization of the Toxic Oligomers.ACS Omega. 2020 Jun 25;5(26):16128-16138. doi: 10.1021/acsomega.0c01730. eCollection 2020 Jul 7. ACS Omega. 2020. PMID: 32656435 Free PMC article.
Publication types
MeSH terms
Substances
Grant support
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical
-
Miscellaneous